Status:
COMPLETED
Is the Exhaled Nitric Oxide in Infants a Predictive Marker of Asthma ?
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Asthma
Eligibility:
All Genders
6-36 years
Phase:
NA
Brief Summary
Background: It seems that in the infants and the young children, the increase of the Exhaled Nitric Oxide (eNO) is in connection with: (1) the risk of developing respiratory symptoms; (2) the risk of...
Detailed Description
This study is a epidemiological observation study
Eligibility Criteria
Inclusion
- Infant between 6 and 36 months
- More than 3 wheezing episodes
- Questionary and biological assessment for recurrent wheeze
- Signature of the consent by 2 parents or by the only one of 2 parents (if this last one is the only present in the inclusion of the child)
Exclusion
- Infant with respiratory disease in neonatal period
- Infant with other obstructive pathology (cystic fibrosis, Primary Ciliary Dyskinesia,…)
- Infant who have a respiratory infection less than 4 weeks
- Infant with asthma exacerbation or who still have corticosteroid treatment
- Infant without social security from their parents
Key Trial Info
Start Date :
January 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2011
Estimated Enrollment :
86 Patients enrolled
Trial Details
Trial ID
NCT01239199
Start Date
January 1 2010
End Date
May 1 2011
Last Update
February 27 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service of multidisciplinary paediatrics (Armand-Trousseau Hospital)
Paris, Île-de-France Region, France, 75012